Logo image of RZLV

REZOLVE AI PLC (RZLV) Stock Fundamental Analysis

USA - NASDAQ:RZLV - GB00BQH8G337 - Common Stock

5.78 USD
+0.8 (+16.06%)
Last: 10/1/2025, 10:13:09 AM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to RZLV. RZLV was compared to 281 industry peers in the Software industry. RZLV may be in some trouble as it scores bad on both profitability and health. RZLV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RZLV has reported negative net income.
RZLV had a negative operating cash flow in the past year.
In the past 5 years RZLV always reported negative net income.
In the past 5 years RZLV always reported negative operating cash flow.
RZLV Yearly Net Income VS EBIT VS OCF VS FCFRZLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

RZLV's Return On Assets of -872.47% is on the low side compared to the rest of the industry. RZLV is outperformed by 98.22% of its industry peers.
Industry RankSector Rank
ROA -872.47%
ROE N/A
ROIC N/A
ROA(3y)-292.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RZLV Yearly ROA, ROE, ROICRZLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

RZLV has a better Gross Margin (81.84%) than 88.26% of its industry peers.
The Profit Margin and Operating Margin are not available for RZLV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RZLV Yearly Profit, Operating, Gross MarginsRZLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K

More info and screens

0

2. Health

2.1 Basic Checks

RZLV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RZLV has more shares outstanding
RZLV has a worse debt/assets ratio than last year.
RZLV Yearly Shares OutstandingRZLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M
RZLV Yearly Total Debt VS Total AssetsRZLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

RZLV has an Altman-Z score of -28.51. This is a bad value and indicates that RZLV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RZLV (-28.51) is worse than 93.95% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -28.51
ROIC/WACCN/A
WACC9.91%
RZLV Yearly LT Debt VS Equity VS FCFRZLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

RZLV has a Current Ratio of 0.23. This is a bad value and indicates that RZLV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.23, RZLV is not doing good in the industry: 95.73% of the companies in the same industry are doing better.
RZLV has a Quick Ratio of 0.23. This is a bad value and indicates that RZLV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of RZLV (0.23) is worse than 95.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
RZLV Yearly Current Assets VS Current LiabilitesRZLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

RZLV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2570.28%.
EPS 1Y (TTM)-2570.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-493.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.43%

3.2 Future

Based on estimates for the next years, RZLV will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.68% on average per year.
Based on estimates for the next years, RZLV will show a very strong growth in Revenue. The Revenue will grow by 738.98% on average per year.
EPS Next Y-176.19%
EPS Next 2Y-30.93%
EPS Next 3Y19.68%
EPS Next 5YN/A
Revenue Next Year14221.3%
Revenue Next 2Y1899.51%
Revenue Next 3Y738.98%
Revenue Next 5YN/A

3.3 Evolution

RZLV Yearly Revenue VS EstimatesRZLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 50M 100M 150M
RZLV Yearly EPS VS EstimatesRZLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RZLV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RZLV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RZLV Price Earnings VS Forward Price EarningsRZLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RZLV Per share dataRZLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

RZLV's earnings are expected to grow with 19.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.93%
EPS Next 3Y19.68%

More info and screens

0

5. Dividend

5.1 Amount

RZLV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REZOLVE AI PLC

NASDAQ:RZLV (10/1/2025, 10:13:09 AM)

5.78

+0.8 (+16.06%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-24 2025-04-24
Earnings (Next)N/A N/A
Inst Owners4.63%
Inst Owner ChangeN/A
Ins Owners32.18%
Ins Owner ChangeN/A
Market Cap1.52B
Analysts81.67
Price Target6.25 (8.13%)
Short Float %8.13%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.52%
EPS NY rev (3m)-17.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.76%
Revenue NY rev (3m)5.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8115.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS-0.14
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -872.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.84%
FCFM N/A
ROA(3y)-292.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1566.18%
Cap/Sales 1878.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z -28.51
F-Score5
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)772.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2570.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-493.89%
EPS Next Y-176.19%
EPS Next 2Y-30.93%
EPS Next 3Y19.68%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.43%
Revenue Next Year14221.3%
Revenue Next 2Y1899.51%
Revenue Next 3Y738.98%
Revenue Next 5YN/A
EBIT growth 1Y-4849.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-17.57%
EBIT Next 3Y46.19%
EBIT Next 5YN/A
FCF growth 1Y-1253.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1063.59%
OCF growth 3YN/A
OCF growth 5YN/A